survodutide vs semaglutide Survodutide: GLP-1 vs Dual Agonist Compared - Which Is Better? | PPW difference from semaglutide and tirzepatide

Federal regulators have added new warnings to Ozempic, Wegovy, Mounjaro and similar drugs that are part of a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1s), indicating that the popular diabetes and weight loss treatments have been linked to incidents of pulmonary aspiration among patients undergoing elective surgeries

GLP-1 RAs slow both liquid and solid transit, meaning material stays in the stomach longer than expected under normal fasting physiology

The Ozempic Lawsuit involves claims that this type of diabetes and weight loss medication has caused severe gastrointestinal side effects for users who were not adequately warned of risks

Our team is here to support you through every stage of your weight loss journey, with safety, clarity, and care at the centre of everything we do

Compounded versions are also available through some telehealth providers